Body mass index and migraine in adolescence: A nationwide study.


Journal

Cephalalgia : an international journal of headache
ISSN: 1468-2982
Titre abrégé: Cephalalgia
Pays: England
ID NLM: 8200710

Informations de publication

Date de publication:
10 2023
Historique:
medline: 27 10 2023
pubmed: 26 10 2023
entrez: 26 10 2023
Statut: ppublish

Résumé

The association between body mass index (BMI) and migraine in adults has been well established. However, studies in children and adolescents are inconclusive. We aimed to study the association between BMI and migraine using a national dataset that comprises the electronic medical records of more than two million adolescents. This study included all Israeli adolescents (57.7% males, 42.3% females; mean age 17 years) who were medically assessed before mandatory military service during 1990-2020. As part of the pre-recruitment medical assessment, all the adolescents were screened for migraine and their height and weight were measured. Diagnoses of migraine were confirmed by board-certified neurologists. Prevalences and odds ratios (ORs) for migraine were computed across BMI subgroups. Spline models were applied. A total of 2,094,862 adolescents were included, of whom 57,385 (2.8%) had active migraine. Among males, the adjusted ORs for migraine were 1.11 (95% confidence interval, 1.06-1.16), 1.13 (1.08-1.17), and 1.24 (1.19-1.30), for the underweight, overweight, and obesity subgroups, respectively, compared to the reference group of low-normal BMI (5th-49th percentile). Among females, the respective adjusted ORs were 1.12 (1.05-1.19), 1.23 (1.19-1.28), and 1.38 (1.31-1.46). Results persisted in sensitivity analyses accounting for other medical and psychiatric comorbidities and parental history of migraine. Spline models demonstrated a J-shaped relation between BMI and migraine. Both adolescent obesity and underweight were associated with migraine in a sex-dependent manner. This association peaked in female adolescents with overweight and obesity.

Sections du résumé

BACKGROUND
The association between body mass index (BMI) and migraine in adults has been well established. However, studies in children and adolescents are inconclusive. We aimed to study the association between BMI and migraine using a national dataset that comprises the electronic medical records of more than two million adolescents.
METHODS
This study included all Israeli adolescents (57.7% males, 42.3% females; mean age 17 years) who were medically assessed before mandatory military service during 1990-2020. As part of the pre-recruitment medical assessment, all the adolescents were screened for migraine and their height and weight were measured. Diagnoses of migraine were confirmed by board-certified neurologists. Prevalences and odds ratios (ORs) for migraine were computed across BMI subgroups. Spline models were applied.
RESULTS
A total of 2,094,862 adolescents were included, of whom 57,385 (2.8%) had active migraine. Among males, the adjusted ORs for migraine were 1.11 (95% confidence interval, 1.06-1.16), 1.13 (1.08-1.17), and 1.24 (1.19-1.30), for the underweight, overweight, and obesity subgroups, respectively, compared to the reference group of low-normal BMI (5th-49th percentile). Among females, the respective adjusted ORs were 1.12 (1.05-1.19), 1.23 (1.19-1.28), and 1.38 (1.31-1.46). Results persisted in sensitivity analyses accounting for other medical and psychiatric comorbidities and parental history of migraine. Spline models demonstrated a J-shaped relation between BMI and migraine.
CONCLUSIONS
Both adolescent obesity and underweight were associated with migraine in a sex-dependent manner. This association peaked in female adolescents with overweight and obesity.

Identifiants

pubmed: 37882650
doi: 10.1177/03331024231209309
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3331024231209309

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Yair Zloof (Y)

Israel Defense Forces Medical Corps, Ramat Gan, Israel.
Department of Preventive Medicine and Epidemiology, School of Public Health, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Schneider Children's Medical Center of Israel, Petach Tikva, Israel.

Avishai M Tsur (AM)

Israel Defense Forces Medical Corps, Ramat Gan, Israel.
Department of Preventive Medicine and Epidemiology, School of Public Health, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Medicine, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Department of Military Medicine, Hebrew University, Jerusalem, Israel.

Maya Simchoni (M)

Israel Defense Forces Medical Corps, Ramat Gan, Israel.
Department of Military Medicine, Hebrew University, Jerusalem, Israel.

Estela Derazne (E)

Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Dorit Tzur (D)

Israel Defense Forces Medical Corps, Ramat Gan, Israel.

Asaf Honig (A)

Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Maya Braun (M)

Israel Defense Forces Medical Corps, Ramat Gan, Israel.

Esther Ganelin-Cohen (E)

Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Institute of Pediatric Neurology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.

Gil Amarilyo (G)

Institute of Pediatric Neurology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Pediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.

Orit Pinhas-Hamiel (O)

Institute of Pediatric Neurology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Pediatric Endocrinology and Diabetes Unit, Edmond and Lili Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

Arnon Afek (A)

Institute of Pediatric Neurology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Central Management Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

Gilad Twig (G)

Israel Defense Forces Medical Corps, Ramat Gan, Israel.
Department of Preventive Medicine and Epidemiology, School of Public Health, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH